Microplate-based assays are vital in life science research, drug discovery, and analytical testing. As laboratories seek greater accuracy, efficiency, and reproducibility, advances in assay technologies, detection methods, and automation are helping researchers generate more reliable data and streamline complex experimental workflows.
This Advances in Microplate-Based Assays and Analysis eBook brings together insights into the technologies, methodologies, and analytical developments shaping modern laboratory research. The collection explores advances in endotoxin testing, ELISA, cell viability monitoring, bacterial growth analysis, and quantitative detection techniques.
As experimental demands become more complex, maintaining assay consistency and optimizing measurement performance are increasingly important. This edition examines best practices for kinetic endotoxin assays, approaches to maintaining cell viability during extended experiments, and methods for monitoring bacterial growth under changing culture conditions.
The eBook also covers developments in quantitative lateral flow assays for LDH detection, including strategies to improve assay sensitivity and performance. Beyond individual assays, it highlights how automated PMT gain adjustment and multiplex TR-FRET technologies are supporting more reliable measurements, efficient data acquisition, and streamlined analytical workflows.
Whether you work in life science research, pharmaceutical development, biotechnology, or laboratory analysis, this eBook provides an overview of the technologies and techniques that help researchers improve assay performance, enhance reproducibility, and gain greater confidence in their analytical results.
About Molecular Devices UK Ltd
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California, with offices around the globe. For more information, please visit www.moleculardevices.com.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.